RegeneRx Biopharmaceuticals, Inc. (NYSEMKT:RGN)

CAPS Rating: No stars

The Company is a biopharmaceutical company that focuses on the discovery and development of novel molecules to accelerate tissue and organ repair.

Recs

0
Player Avatar pennysplants (99.58) Submitted: 11/23/2012 12:10:16 PM : Outperform Start Price: $2.55 RGN Score: -89.32

Busted ! Cleaning up after 2 year hiatus from CAPS.

Featured Broker Partners


Advertisement